1
Return

Flavouring Group Evaluation 216 Revision 3 (FGE.216Rev3): Consideration of the genotoxic potential of α,β-unsaturated 2-phenyl-2-alkenals from subgroup 3.3 of FGE.19

delete2026-07-02
delete0
delete
OA
AI
E
EFSA Panel on Food Additives and Flavourings (FAF)
L
Laurence Castle
M
Monica Andreassen
G
Gabriele Aquilina
M
Maria Bastos
P
Polly Boon
B
Biagio Fallico
R
Rex FitzGerald
M
María José Frutos Fernández
B
Bettina Grasl-Kraupp
U
Ursula Gundert-Remy
R
Rainer Gürtler
E
Eric Houdeau
M
Marcin Kurek
H
Henriqueta Louro
P
Patricia Morales
S
Sabina Passamonti
C
Claudia Bolognesi
E
Eugenia Cordelli
G
Gisela Degen
K
Karl-Heinz Engel
M
Maria Carfí
A
Alessandra Tosato
C
Carla Martino
DOI:10.2903/j.efsa.2026.10148delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
The EFSA Panel on Food Additives and Flavourings (FAF) evaluated the genotoxic potential of two flavouring substances, 2-phenylcrotonaldehyde [FL-no: 05.062] and 5-methyl-2-phenylhex-2-enal [FL-no: 05.099] from subgroup 3.3 of FGE.19, in the Flavouring Group Evaluation 216 revision 3 (FGE.216Rev3). In FGE.216Rev2, the Panel concluded that the use of the flavouring [FL-no: 05.062] at the reported use levels in several food categories would raise a concern for aneugenicity and requested substance-specific data for the other related compounds [FL-no: 05.099, 05.100, 05.175 and 05.222]. New data were provided only for [FL-no: 05.062 and 05.099]. For [FL-no: 05.062], the results of a new plasma analysis of the exposed animals were considered to be sufficient to rule out a concern for systemic aneugenicity of the substance. However, the data available do not overrule the concern for aneugenicity of 2-phenylcrotonaldehyde at the site of contact, where the concentrations will be maximal, taking into account that the positive findings in the in vitro micronucleus (MN) assay were seen only in the absence of metabolic activation. Therefore, in line with the principles described in the EFSA Scientific Committee guidance on aneugenicity, the Panel compared the lowest concentration resulting in aneugenicity in the in vitro MN assay (20 μg/mL) with the reported use levels of 2-phenylcrotonaldehyde [FL-no: 05.062] in food (up to 2 mg/kg) and noted that they are one order of magnitude below the concentration for which an aneugenic effect was observed in the in vitro MN assay. Based on this comparison, the Panel concluded that the use of the flavouring substance [FL-no: 05.062] in foods, including beverages, would not raise a concern for aneugenicity if the use levels were not greater than 2 mg/kg or mg/L. For [FL-no: 05.099], based on the new data available, the Panel concluded that there is no concern for genotoxicity.
Keywords:
α,β-unsaturated 2-phenyl-2-alkenals
FGE.19
FGE.216
flavouring substances
subgroup 3.3
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

EFSA Journal cover
EFSA Journal
IF:
3.3
Papers:
4.1K
Citations:
1.9W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers